期刊文献+

凝血酶敏感蛋白-1及相关因子对垂体瘤侵袭性影响的研究 被引量:2

Researches on the effect of thrombospondin-1, CD36, TGF-β1 in pituitary adenomas
原文传递
导出
摘要 目的探讨垂体瘤中凝血酶敏感蛋白-1(TSP-1)、CD36、转化生长因子β1(TGF—β1)的表达及其与肿瘤侵袭性的关系。方法取52例垂体瘤(侵袭性组24例,非侵袭性组28例)手术标本,采用RT-PCR检测TSP-1、CD36、TGF-β1的mRNA表达,Western blot方法检测TSP-1、TGF-β1蛋白表达,并分析其表达与垂体瘤侵袭性等因素之间的关系。结果与非侵袭组相比,侵袭组TSP-1 mRNA及蛋白表达较弱,TGF-β1 mRNA及蛋白表达则强于非侵袭性组(P〈0.05),两组间CD36 mRNA表达差异无显著性意义(P〉0.05)。肿瘤的大小组间、各内分泌功能分型组间TSP-1、TGF-β1、CD36差异均无显著性意义(P〉0.05)。结论TSP-1、TGF—β1 mRNA及蛋白表达与垂体瘤侵袭性密切相关,提示其可能在垂体瘤发生发展中起重要作用,并能影响垂体瘤的侵袭性。 Objective To explore the expressions ofthrombospondin-1 (TSP-1), transforming growth factor β1 (TGF-β1), CD36 in pituitary adenomas and investigate the relationships between the expressions and the invasiveness of adenomas. Methods The mRNA expressions of TSP-1, TGF-β1, CD36 in 52 surgical specimens (24 invasive cases; 28 noinvasive cases) of pituitary adenomas was measured using RT-PCR and Western blot method was used to detect the protein levels of TSP-1 and TGF-β1. The correlations between the expressions and invasiveness of adenomas were analyzed. Results In invasive group as compared with the noinvasive group, the expression of TSP-1 (mRNA: t=4.389, P=000; protein: t=4.207, P=0001) was lower, and the expression of TGF-β1 (mRNA: r= 3.356, P=004; protein: t=5.59, P〈0.0001) was stronger, and the mRNA expression of CD36 (t=2.279, P= 0.063) was not significantly different. No difference in the expressions of TSP-1, TGF-β1 and CD36 was seen between different groups of various tumor sizes and endocrine functional types. Conclusion TSP-1 and TGF-β1 maybe play an important role in the development of pituitary adenomas and regulate its invasiveness.
出处 《中华神经医学杂志》 CAS CSCD 2007年第1期18-21,共4页 Chinese Journal of Neuromedicine
关键词 凝血酶敏感蛋白-1 CD36 转化生长因子Β1 垂体瘤 Thrombospondin-1 CD36 TGF-β1 Pituitary adenomas
  • 相关文献

参考文献13

  • 1Fraipont F, Nicholson AC, Feige JJ, et al. Thrombospondins and tumor angiogenesis[J]. Trends Mol Med, 2001, 7(9): 401-407.
  • 2Ikezu T, Okamoto T, Yonezawa K, et al. Analysis of thermal injury-induced insulin resistance in rodents[J]. Biochem J, 1997,272(40): 25289-25295.
  • 3Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenis witch during tumorigenesis [J]. Cell, 1996, 86 (3):353-364.
  • 4Itoh J, Serizawa A, Kawai K, et al. Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas [J]. Microsc Res Tech, 2003, 60 (2):
  • 5Abdelouahed M, Ludlow A, Brunner G, et al. Activation of platelet-transforming growth factor beta-1 in the absence of thrombospondin-1 [J]. J Biol Cbem, 2000, 275(24): 17933-17936.
  • 6Renner U, Lohrer P, Schaaf L, et al. Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells[J]. Endocrinology, 2002, 143(10):3759-3765.
  • 7Horiguchi H, Jin L, Ruebel H, et al. Regulation of VEGF-A,VEGFR-I, thrombospondin-1, -2, and -3 expression in a human pituitary cell line (HP75) by TGF [beta] 1, bFGF, and EGF [J].Endocrine, 2004, 24(2): 141-146.
  • 8Nakagawa T, Lan HY, Glushakova O, et al. Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-betal in rat proximal tubular cells and mouse fibroblasts[J]. J Am Soc Nephrol, 2005, 16(4): 899-904.
  • 9NorJ E, Mitra RS, Sutorik MM, et al. Thrombospondin 1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway[J]. J Vasc Res, 2000, 37(3): 209-218.
  • 10Pratt DA, Miller WR, Dawes J. Thrombospondin in malignant and non-malignant breast tissue[J]. Eur J Cancer Clin Oncol, 1989, 25(2): 343-350.

同被引文献38

  • 1杨伟,曲元明,徐广明,韩韬,牟成志.在垂体腺瘤中TSP-1和TGF-β1的表达及其与微血管密度的关系[J].中华内分泌代谢杂志,2007,23(1):44-46. 被引量:6
  • 2张庆原,张剑宁.VEGF、uPA在侵袭性垂体腺瘤中的表达及意义[J].中华神经外科疾病研究杂志,2007,6(2):146-149. 被引量:3
  • 3Fraipont F D, Nicholson A C, Feige J J, et al. Thrombospondins and tumor angiogenesis [ J ]. Trends Mol Med, 2001 , 7(9):401-407.
  • 4Fazekas I, Hegedus B, Bacsy E, et al. Characterization of human pituitary adenomas in cell cultures by light and electron microscopic morphology and immunolabeling [ J ]. Folia Histochem Cytobiol, 2005, 43 ( 2 ) : 81-90.
  • 5John A S, Hu X, Rothman V L, et al. Thrombospondin- 1 ( TSP-1 ) up-regulates tissue inhibitor of metalloproteinase-1 ( TIMP-1 ) production in human tumor cells : exploring the functional significance in tumor cell invasion[J]. Exp Mol Pathol, 2009, 87(3) :184-188.
  • 6Aishima S, Taguchi K, Sugimachi K, et al. The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinoma [J]. Int J Surg Pathol, 2002, 10( 1 ) :47-56.
  • 7Oshiba G, Kijima H, Himeno S, et al. Stromal thrombospondin-1 expression is correlated with progression of esophageal squarnous cell carcinomas [ J ]. Anticancer Res, 1999, 19(5C) :4375-4378.
  • 8Ohtani Y, Kijima H, Dowaki S, et al. Stromal expression of thrombospondin-1 is correlated with growth and metastasis of human gallbladder carcinoma [ J ]. Int J Oncol, 1999, 15(3): 453-457.
  • 9Scarpino S, Di Napoli A, Taraboletti G, et al. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 ( TSP-1 ) expression in thyroid papillary carcinoma cells [J]. J Pathol, 2005, 205 (1):50-56.
  • 10Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer [ J ]. Cancer, 2003, 97 ( 8 Suppl) : 2083-2089.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部